Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Inhibitors of Bacterial DNA Synthesis

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Fluorescence Immunosensor with Phage Antibodies for Heat Shock Protein 70 Detection.

Biosensors·2026

Same author

Multifunctional nanozyme systems for combating bacterial infections in wound treatment.

Talanta·2026

Same author

Screening of anticancer drugs against potential carcinogenic bacterial virulence proteins in colorectal cancer: An in silico approach.

The Journal of pharmacology and experimental therapeutics·2026

Same author

Gold-based nanohybrid materials in biosensing.

Talanta·2025

Same author

Nanozymes: a dual approach to bacterial colorimetric and luminescent detection and to bacterial pathogen killing.

Biosensors & bioelectronics·2025

Same author

Bacteria- and Phage-Derived Proteins in Phage Infection.

Frontiers in bioscience (Landmark edition)·2025

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Endolysins and Their Potential in Combating Bacterial Multidrug Resistance.

Olga I Guliy¹, Olga A Karavaeva¹

¹Institute of Biochemistry and Physiology of Plants and Microorganisms - Subdivision of the Federal State Budgetary Research Institution Saratov Federal Scientific Centre of the Russian Academy of Sciences (IBPPM RAS), 410049 Saratov, Russia.

Frontiers in Bioscience (Elite Edition)

|July 7, 2026

Summary

Bacteriophage endolysins show promise as novel antibacterial agents to combat rising antibiotic resistance and bacterial infections, including biofilms. Their therapeutic potential is being explored alongside innovative strategies like artificial intelligence.

Keywords:

bacteriophages endolysins infection multidrug resistance therapy

More Related Videos

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

Related Experiment Videos

Last Updated: Jul 8, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

Area of Science:

Microbiology and Infectious Diseases
Biotechnology and Drug Discovery

Background:

Antibiotic resistance is a growing global health crisis, with multidrug-resistant pathogens causing millions of deaths annually.
Traditional antibiotics face limitations due to widespread bacterial resistance, necessitating the exploration of novel therapeutic strategies.
Bacteriophage-derived enzymes, specifically endolysins, are emerging as potent alternatives to conventional antibiotics.

Purpose of the Study:

To review the achievements and mechanisms of bacteriophage endolysins against bacterial infections.
To discuss the therapeutic potential of endolysins in overcoming antibiotic resistance and combating biofilms.
To explore novel strategies, including combination therapies and artificial intelligence, for antimicrobial-resistant infections.

Main Methods:

Comprehensive literature review of bacteriophage endolysins and their antibacterial properties.
Analysis of endolysin mechanisms of action against various bacterial pathogens and biofilms.
Discussion of current research trends and future therapeutic applications.

Main Results:

Bacteriophage endolysins demonstrate potent lytic activity against a broad spectrum of bacteria, including multidrug-resistant strains.
Endolysins are effective against bacterial biofilms, a significant challenge in treating chronic infections.
Emerging research highlights the potential of combining endolysins with other molecules and leveraging AI for enhanced efficacy.

Conclusions:

Bacteriophage endolysins represent a promising class of nonclassical antibiotics with significant therapeutic potential against resistant bacteria.
Further research and clinical trials are warranted to fully realize the clinical application of endolysins.
Innovative approaches, including combination therapies and AI, are crucial for addressing the escalating threat of antimicrobial resistance.